AENCO: A Health care Ecosystem

AENCO: A Health care Ecosystem

Health tech, or digital health, uses technology (databases, applications, mobiles, wearables) to improve the delivery, payment, and/or consumption of care, with the ability to increase the development and commercialization of medicinal products.
Creating a definition for Health Tech is a bit difficult considering that the sector has an endless list of possible uses for technology within its many operations, services and stakeholders. Sub-sectors include: hospitals and practitioners; insurance; pharmaceuticals; and government – and even as consumers and businesses alike are beginning to realize the potential of the partnership between technology and the health industry, reports suggest that its trajectory is brighter still.

Challenges to medical innovation

The health care sector is highly complex, and the medical care delivery ecosystem is under increasing pressures due to rising costs and patient expectations. These pressures and the inherent nature of the industry itself make innovation in health care more complicated than in the consumer products sector.

To break through the complexity and move innovation in medicine forward, inventors and product research and manufacturing companies must first overcome the many barriers to healthcare product development. Here are some of the barriers:
To be successful, a new healthcare innovation must improve upon the current standard of medical care without causing harm to the patient and ideally lower costs simultaneously. But gaining access to medical professionals with the appropriate specialized expertise to determine medical efficacy can pose a major obstacle to even the largest, most established companies, not to mention the individual inventor.

Funding for emerging biotechnology and medical technology companies are intrinsically difficult. Also, fund raising channels are conventionally dominated by the largest actors like the investment banks, etc. another challenge, particularly for angel investments is the constant pressure to source from numerous smaller investors which can create serious administrative burden, and lose focus from actual research and development activities of entrepreneurs.
Gaining access to quality manufacturers is a major hurdle for many healthcare inventors because of concerns that manufacturers have about “intellectual property contamination” issues.

The Aenco platform as a solution

Aenco describes itself as a blockchain based global financial solution platform bringing to bear, many years of experience in conventional financial services and prime brokerage, with network of healthcare technology innovation partners and new-age applications, collectively developed under the umbrella Aenco global healthtech financial solutions platform.

The goal of the platform is to found an international complete- service blockchain based financial solutions, while functioning within an internationally sanctioned regulatory framework in preemption of increasing regulatory requirements by making use of a decentralized blockchain based financial environment that combines traditional or conventional and modern methods of capital market services and operations. The services will be supported and anchored upon a local and internally developed core utility token “AEN” as a medium of exchange that is exchangeable with recognized major crypto like Bitcoins and Ethereum.
The Aenco solution will fund, take-part and facilitate deep impact healthcare technology growth companies that have dreams in creating positive and deep changes to our society. This will be done through their participation in developing the respective token ecosystems, if need be through their multi- jurisdictional regulated infrastructure under the gold standard of best practice.



AENCO: A Healthcare Ecosystem



Health tech, or digital health, uses technology (databases, applications, mobiles, wearables) to improve the delivery, payment, and/or consumption of care, with the ability to increase the development and commercialization of medicinal products.
Creating a definition for Health Tech is a bit difficult considering that the sector has an endless list of possible uses for technology within its many operations, services and stakeholders. Sub-sectors include: hospitals and practitioners; insurance; pharmaceuticals; and government – and even as consumers and businesses alike are beginning to realize the potential of the partnership between technology and the health industry, reports suggest that its trajectory is brighter still.

Challenges to medical innovation

The healthcare sector is highly complex, and the medical care delivery ecosystem is under increasing pressures due to rising costs and patient expectations. These pressures and the inherent nature of the industry itself make innovation in healthcare more complicated than in the consumer products sector.

To break through the complexity and move innovation in medicine forward, inventors and product research and manufacturing companies must first overcome the many barriers to healthcare product development. Here are some of the barriers:
To be successful, a new healthcare innovation must improve upon the current standard of medical care without causing harm to the patient and ideally lower costs simultaneously. But gaining access to medical professionals with the appropriate specialized expertise to determine medical efficacy can pose a major obstacle to even the largest, most established companies, not to mention the individual inventor.

Funding for emerging biotechnology and medical technology companies are intrinsically difficult. Also, fundraising channels are conventionally dominated by the largest actors like the investment banks, etc. another challenge, particularly for angel investments is the constant pressure to source from numerous smaller investors which can create serious administrative burden, and lose focus from actual research and development activities of entrepreneurs.
Gaining access to quality manufacturers is a major hurdle for many healthcare inventors because of concerns that manufacturers have about “intellectual property contamination” issues.

The Aenco platform as a solution

Aenco describes itself as a blockchain based global financial solution platform bringing to bear, many years of experience in conventional financial services and prime brokerage, with network of healthcare technology innovation partners and new-age applications, collectively developed under the umbrella Aenco global healthtech financial solutions platform.

The goal of the platform is to found an international complete- service blockchain based financial solutions, while functioning within an internationally sanctioned regulatory framework in preemption of increasing regulatory requirements by making use of a decentralized blockchain based financial environment that combines traditional or conventional and modern methods of capital market services and operations. The services will be supported and anchored upon a local and internally developed core utility token “AEN” as a medium of exchange that is exchangeable with recognized major crypto like Bitcoins and Ethereum.
The Aenco solution will fund, take-part and facilitate deep impact healthcare technology growth companies that have dreams in creating positive and deep changes to our society. This will be done through their participation in developing the respective token ecosystems, if need be through their multi- jurisdictional regulated infrastructure under the gold standard of best practice.



Useful Links:          Website | White Paper | ANN Thread


Author Detail:

My BountyHive Referral:     OrangeSeller
ETH Address:                       0x1461C3727dC461EfF7B32751dFf56c51c2218d5E

No comments

Powered by Blogger.